TSS
CELZ icon

Two Sigma Securities’s Creative Medical Technology CELZ Stock Holding History

Two Sigma Securities’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,758
Closed -$13.8K – 2826
2023
Q1 		$13.8K Buy
2,758
+1,032
+60% +$5.86K ﹤0.01% 2409
2022
Q4 		$6.58K Buy
+1,726
New +$7.1K ﹤0.01% 2426
2022
Q2 		– Sell
-1,326
Closed -$52K – 2263
2022
Q1 		$52K Buy
+1,326
New +$29.5K ﹤0.01% 1867

Other funds holding CELZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
ODG
O'Dell Group Cincinnati, Ohio $466M AUM 13.5% 1-Year Est. Return

Two Sigma Securities's CELZ Position: Q2 2023 in Review

Two Sigma Securities sold out of Creative Medical Technology (CELZ) in Q2 2023, closing a stake of 2,758 shares — an estimated $13.8K sold.

Two Sigma Securities first reported a position in CELZ in Q1 2022 and held it in 3 quarters. The position peaked at $52K in Q1 2022. 9 funds tracked by Wall St. Rank hold CELZ as of Q2 2023.

  • Two Sigma Securities reported no remaining Creative Medical Technology position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Securities sold 2,758 Creative Medical Technology shares in Q2 2023, an estimated $13.8K.
  • Two Sigma Securities first reported a position in Creative Medical Technology in Q1 2022 and held it in 3 quarters.
  • Two Sigma Securities's Creative Medical Technology position peaked at $52K in Q1 2022.
  • 9 funds tracked by Wall St. Rank held Creative Medical Technology as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.